v3.20.2
Equity
 9 Months Ended
Sep. 27, 2020
Equity [Abstract]  
Equity Equity
A. Preferred Stock
Prior to May 4, 2020, Pfizer’s Series A convertible perpetual preferred stock (the Series A Preferred Stock) was held by an employee stock ownership plan trust (the Trust). All outstanding shares of Series A Preferred Stock were converted, at the direction of the independent fiduciary under the Trust and in accordance with the certificate of designations for the Series A Preferred Stock, into shares of Pfizer common stock on May 4, 2020. The Trust received an aggregate of 1,070,369 shares of
Pfizer common stock upon conversion, with zero shares of Series A Preferred Stock remaining outstanding as a result of the conversion.
B. Dividends
The following presents quarterly cash dividends:
20202019
Date
Declared		Payment
Date		Dividend Per
Share		Date
Declared		Payment
Date		Dividend Per Share
December 13, 2019March 6, 2020$0.38 December 14, 2018March 1, 2019$0.36 
April 23, 2020June 5, 20200.38 April 25, 2019June 7, 20190.36 
June 25, 2020September 1, 20200.38 June 27, 2019September 3, 20190.36 
September 24, 2020December 1, 20200.38 September 24, 2019December 2, 20190.36